vs
Privia Health Group, Inc.（PRVA）与RANGE RESOURCES CORP（RRC）财务数据对比。点击上方公司名可切换其他公司
RANGE RESOURCES CORP的季度营收约是Privia Health Group, Inc.的1.5倍（$786.9M vs $541.2M），RANGE RESOURCES CORP净利率更高（22.8% vs 1.7%，领先21.1%），RANGE RESOURCES CORP同比增速更快（18.0% vs 17.4%），过去两年RANGE RESOURCES CORP的营收复合增速更高（14.6% vs 14.2%）
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业，核心运营区域为马塞勒斯页岩地层，是该地区拥有土地面积最大的运营商，专注于天然气资源的勘探、开发与生产业务，在北美油气开发领域具备深厚的行业积累。
PRVA vs RRC — 直观对比
营收规模更大
RRC
是对方的1.5倍
$541.2M
营收增速更快
RRC
高出0.6%
17.4%
净利率更高
RRC
高出21.1%
1.7%
两年增速更快
RRC
近两年复合增速
14.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $541.2M | $786.9M |
| 净利润 | $9.2M | $179.1M |
| 毛利率 | — | 94.5% |
| 营业利润率 | 2.1% | — |
| 净利率 | 1.7% | 22.8% |
| 营收同比 | 17.4% | 18.0% |
| 净利润同比 | 108.0% | 88.8% |
| 每股收益（稀释后） | $0.08 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRVARRC
| Q4 25 | $541.2M | $786.9M | ||
| Q3 25 | $580.4M | $655.3M | ||
| Q2 25 | $521.2M | $699.6M | ||
| Q1 25 | $480.1M | $846.3M | ||
| Q4 24 | $460.9M | $667.0M | ||
| Q3 24 | $437.9M | $567.9M | ||
| Q2 24 | $422.3M | $513.2M | ||
| Q1 24 | $415.2M | $598.8M |
净利润PRVARRC
| Q4 25 | $9.2M | $179.1M | ||
| Q3 25 | $6.9M | $144.3M | ||
| Q2 25 | $2.7M | $237.6M | ||
| Q1 25 | $4.2M | $97.1M | ||
| Q4 24 | $4.4M | $94.8M | ||
| Q3 24 | $3.5M | $50.7M | ||
| Q2 24 | $3.5M | $28.7M | ||
| Q1 24 | $3.0M | $92.1M |
毛利率PRVARRC
| Q4 25 | — | 94.5% | ||
| Q3 25 | — | 92.5% | ||
| Q2 25 | — | 95.0% | ||
| Q1 25 | — | 93.1% | ||
| Q4 24 | — | 93.7% | ||
| Q3 24 | — | 94.3% | ||
| Q2 24 | — | 93.4% | ||
| Q1 24 | — | 94.7% |
营业利润率PRVARRC
| Q4 25 | 2.1% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 0.2% | — |
净利率PRVARRC
| Q4 25 | 1.7% | 22.8% | ||
| Q3 25 | 1.2% | 22.0% | ||
| Q2 25 | 0.5% | 34.0% | ||
| Q1 25 | 0.9% | 11.5% | ||
| Q4 24 | 1.0% | 14.2% | ||
| Q3 24 | 0.8% | 8.9% | ||
| Q2 24 | 0.8% | 5.6% | ||
| Q1 24 | 0.7% | 15.4% |
每股收益（稀释后）PRVARRC
| Q4 25 | $0.08 | $0.75 | ||
| Q3 25 | $0.05 | $0.60 | ||
| Q2 25 | $0.02 | $0.99 | ||
| Q1 25 | $0.03 | $0.40 | ||
| Q4 24 | $0.03 | $0.38 | ||
| Q3 24 | $0.03 | $0.21 | ||
| Q2 24 | $0.03 | $0.12 | ||
| Q1 24 | $0.02 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $479.7M | $204.0K |
| 总债务越低越好 | — | $1.2B |
| 股东权益账面价值 | $737.2M | $4.3B |
| 总资产 | $1.4B | $7.4B |
| 负债/权益比越低杠杆越低 | — | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资PRVARRC
| Q4 25 | $479.7M | $204.0K | ||
| Q3 25 | $441.4M | $175.0K | ||
| Q2 25 | $390.1M | $134.0K | ||
| Q1 25 | $469.3M | $344.6M | ||
| Q4 24 | $491.1M | $304.5M | ||
| Q3 24 | $422.0M | $277.4M | ||
| Q2 24 | $387.4M | $251.1M | ||
| Q1 24 | $351.1M | $343.1M |
总债务PRVARRC
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
股东权益PRVARRC
| Q4 25 | $737.2M | $4.3B | ||
| Q3 25 | $709.1M | $4.2B | ||
| Q2 25 | $682.9M | $4.1B | ||
| Q1 25 | $659.4M | $3.9B | ||
| Q4 24 | $635.2M | $3.9B | ||
| Q3 24 | $614.9M | $3.9B | ||
| Q2 24 | $595.4M | $3.9B | ||
| Q1 24 | $576.8M | $3.8B |
总资产PRVARRC
| Q4 25 | $1.4B | $7.4B | ||
| Q3 25 | $1.4B | $7.2B | ||
| Q2 25 | $1.3B | $7.1B | ||
| Q1 25 | $1.2B | $7.4B | ||
| Q4 24 | $1.1B | $7.3B | ||
| Q3 24 | $1.1B | $7.2B | ||
| Q2 24 | $1.1B | $7.3B | ||
| Q1 24 | $1.0B | $7.4B |
负债/权益比PRVARRC
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $127.5M | $257.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 13.93× | 1.44× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PRVARRC
| Q4 25 | $127.5M | $257.5M | ||
| Q3 25 | $52.0M | $247.5M | ||
| Q2 25 | $8.0M | $336.2M | ||
| Q1 25 | $-24.1M | $330.1M | ||
| Q4 24 | $74.8M | $217.9M | ||
| Q3 24 | $33.2M | $245.9M | ||
| Q2 24 | $34.5M | $148.8M | ||
| Q1 24 | $-33.1M | $331.9M |
现金转化率PRVARRC
| Q4 25 | 13.93× | 1.44× | ||
| Q3 25 | 7.58× | 1.72× | ||
| Q2 25 | 2.97× | 1.42× | ||
| Q1 25 | -5.70× | 3.40× | ||
| Q4 24 | 17.00× | 2.30× | ||
| Q3 24 | 9.38× | 4.85× | ||
| Q2 24 | 9.94× | 5.18× | ||
| Q1 24 | -11.10× | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
